Knee Injuries: Clinical Trials

18 trials for Knee Injuries, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed. 18 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 418Completed 18

Follow Knee Injuries: new trials by email Literature Review of Knee Injuries trials Research Report on Knee Injuries

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nalbuphine With Remimazolam Versus Nalbuphine With Propofol for Knee Arthroscopy
Nalbuphine, Remimazolam, Propofol - Knee Injuries
Phase 4CompletedWuhan Fourth Hospital1002025-04-102026-09-24
Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery
Genicular Nerve Block with bupivacaine and preservative free dexamethasone - ACL, Anterior Cruciate Ligament Injuries
Phase 4CompletedHospital for Special Surgery, New York1922023-01-122026-01-26
iPACK for Post-op Pain Following ACL Reconstruction
Adductor Canal Block (ACB) Only, Adductor Canal Block (ACB) + iPACK Block - ACL Injury, Post Operative Pain
Phase 4CompletedMedical University of South Carolina822022-08-252024-10-16
Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following ACL Reconstruction With Bone Patellar Tendon Bone Autograft:
IPACK block - Anterior Cruciate Ligament Rupture
Phase 4CompletedNYU Langone Health1022022-07-112024-04-26
Are Opioids Needed After ACL Reconstruction
Oxycodone, Placebo oral tablet - Anterior Cruciate Ligament Rupture
Phase 4CompletedEmory University982020-09-162023-10-11
A Novel Analgesia Technique for ACL Reconstruction
Bupivacaine, Ultrasound, Dexamethasone - Anterior Cruciate Ligament Injury
Phase 4CompletedHospital for Special Surgery, New York782017-10-042024-09-19
Effect of PRP Injection After Arthroscopic Meniscal Repair in the Healing Process
platelet rich plasma - Knee Pain, Knee Injuries
Phase 4CompletedAlexandria University302017-03-032019-04-11
Clinical Comparison of Femoral Nerve Versus Adductor Canal Block Following Anterior Ligament Reconstruction
30 ml of 0.2% ropivacaine, 15 ml of 0.2% ropivacaine, 100 mcg clonidine - Anterior Cruciate Ligament Injury
Phase 4CompletedThe University of Texas Health Science Center, Houston1252016-02-012021-10-21
Adductor Canal Block Versus Femoral Block on Pain and Quadriceps Strength
Femoral Nerve Block, Adductor Canal Nerve Block, preoperative Femoral Nerve Block using 20ml of 0.5% ropivacaine - Anterior Cruciate Ligament Tear, Knee Meniscus Tear
Phase 4CompletedUniversity of California, San Francisco1322016-01-012025-09-30
Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament Reconstruction
Ropivacaine 0.5% 20 mLs - Rupture of Anterior Cruciate Ligament, Infiltration
Phase 4CompletedCentre Hospitalier Universitaire Vaudois1042015-09-012018-05-07
Liposomal Bupivacaine for Pain Control Following Anterior Cruciate Ligament Reconstruction
Exparel - Anterior Cruciate Ligament Rupture
Phase 4CompletedEmory University502014-08-012016-07-27
Ultrasound-guided Adductor Canal Block for Total Knee Replacement
Bupivacaine, Preservative free normal saline - Complications; Arthroplasty, Knee Injuries
Phase 4CompletedNorthwestern University402014-03-012017-07-11
Simultaneous Multiple Cruciate Ligament Reconstructions Using a Single Achilles Allograft
cruciate ligament reconstruction - Rupture of Posterior Cruciate Ligament, Rupture of Anterior Cruciate Ligament
Phase 4CompletedNational Police Hospital512011-05-012011-09-26
Comparison of Infiltration Analgesia With Femoral Nerve Block After Hamstrings Anterior Cruciate Ligament Reconstruction
Femoral nerve block, Local infiltration analgesia - Injury of Anterior Cruciate Ligament
Phase 4CompletedUniversity of Aarhus602010-11-012012-05-02
Acute Pain and Inflammation After Surgery
1 Ketorolac intraarticular, Placebo - Knee Injuries
Phase 4CompletedOslo University Hospital402008-08-012015-04-23
Evaluation of Biocleanse Allografts For ACL Reconstruction
ACL reconstruction control, ACL Biocleanse, surgical - Anterior Cruciate Ligament Tear
Phase 4CompletedUniversity of Florida672004-02-012014-03-04
COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined
parecoxib, valdecoxib, etoricoxib, Dexamethasone, parecoxib, valdecoxib, parecoxib and dexamethasone - Rupture of Anterior Cruciate Ligament
Phase 4CompletedAsker & Baerum Hospital932004-01-012011-05-27
Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction
Single-injection femoral nerve block, Femoral nerve block 60-hour continuous injection, Saline (control) injection into femoral nerve envelope - Anterior Cruciate Ligament Rupture
Phase 4CompletedUniversity of Pittsburgh2702001-05-012013-05-03

Narrower conditions

Anterior Cruciate Ligament Injuries (14)  ·  Acute Pain (1)  ·  Agnosia (1)  ·  Pain (1)  ·  Pain, Postoperative (1)

Broader conditions

Leg Injuries (18)  ·  Wounds and Injuries (18)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Pain (2)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Pathologic Processes (1)  ·  Perceptual Disorders (1)  ·  Postoperative Complications (1)

Interventions

Bupivacaine (3)  ·  Ropivacaine (3)  ·  Sodium Chloride (3)  ·  Dexamethasone (2)  ·  Calcium Dobesilate (1)  ·  Clonidine (1)  ·  Etoricoxib (1)  ·  Ketorolac (1)  ·  Nalbuphine (1)  ·  Oxycodone (1)  ·  Propofol (1)  ·  Single Person (1)  ·  Surgical Procedures, Operative (1)  ·  Ultrasonography (1)  ·  parecoxib (1)

Sponsors

Emory University (2)  ·  Hospital for Special Surgery, New York (2)  ·  Alexandria University (1)  ·  Asker & Baerum Hospital (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Medical University of South Carolina (1)  ·  NYU Langone Health (1)  ·  National Police Hospital (1)  ·  Northwestern University (1)  ·  Oslo University Hospital (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University of Aarhus (1)  ·  University of California, San Francisco (1)  ·  University of Florida (1)  ·  University of Pittsburgh (1)

Countries

United States (11)  ·  Norway (2)  ·  China (1)  ·  Denmark (1)  ·  Egypt (1)  ·  South Korea (1)  ·  Switzerland (1)

Top investigators

John Xerogeanes, MD (2)  ·  Antoun Nader, MD (1)  ·  Brian A. Williams, MD, MBA (1)  ·  Carey Breabaker, MD (1)  ·  David H Kim, MD (1)  ·  Eric Albrecht, PD Dr (1)  ·  Eric J Strauss, MD (1)  ·  Jashvant Poeran, MD/PhD (1)  ·  Jonathan Beathe, MD (1)  ·  Jung Ho Noh, M.D., Ph.D. (1)  ·  Lane Bailey, PhD, PT (1)  ·  Leiv Arne Rosseland (1)  ·  Pedram Aleshi, MD (1)  ·  Peter A. Indelicato, M.D. (1)  ·  Rehab A ELnemr, lecturer (1)

Results publications

PMID 16436852, PMID 17377133, PMID 17456710, PMID 17543812, PMID 17543813, PMID 18042869, PMID 18073577, PMID 23338666, PMID 27159290, PMID 30733025, PMID 31130273, PMID 31348866, PMID 34477016, PMID 36860772, PMID 37152546, PMID 40308075, PMID 42459597

NIH funding

2004 (1), K23AR047631 (1)